Home › Funds › Sarasin & Partners LLP › AMGN
Sarasin & Partners LLP position in AMGN
AMGEN INC · Health Care
Sarasin & Partners LLP reported holding 180,232 shares of AMGN (AMGEN INC) in its Q3 2026 13F filing — a position valued at US$76.0M, representing 0.85% of its reported portfolio and ranking #34 among its reported holdings. Sarasin & Partners LLP has disclosed AMGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How Sarasin & Partners LLP's AMGN position evolved
Sarasin & Partners LLP first disclosed a stake in AMGN in Q3 2023 at 1,183,811 shares (US$318.2M). The position peaked in Q2 2024 at 1,128,536 shares, worth US$352.6M. Across 13 filings, Sarasin & Partners LLP increased the stake 4 time(s), trimmed it 8 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 180,232 shares valued at US$76.0M — a reduction of -163,716 shares quarter over quarter.. Notable position changes include a 35% trim in Q4 2024 (shares rose 19% over the following quarter), a 48% trim in Q2 2026 (shares rose 16% over the following quarter), a 48% trim in Q3 2026 (shares rose 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 1.18M | $318.16M | New |
| Q4 2023 | 1.15M | $330.56M | Reduce |
| Q1 2024 | 1.14M | $324.52M | Reduce |
| Q2 2024 | 1.13M | $352.61M | Reduce |
| Q3 2024 | 818.40K | $263.70M | Reduce |
| Q4 2024 | 532.30K | $138.74M | Reduce |
| Q1 2025 | 557.54K | $173.70M | Add |
| Q2 2025 | 612.12K | $170.91M | Add |
| Q3 2025 | 659.99K | $180.82M | Add |
| Q4 2025 | 655.51K | $214.56M | Reduce |
| Q1 2026 | 666.45K | $234.49M | Add |
| Q2 2026 | 343.95K | $124.55M | Reduce |
| Q3 2026 | 180.23K | $75.97M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About AMGN and 13F data
AMGN (AMGEN INC) is a Health Care company. 32 other funds we track also report a position in AMGN — the largest reported positions include BlackRock Inc (US$17.87B), STATE STREET CORP (US$10.75B), Capital World Investors (US$10.53B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding AMGN
- BlackRock Inc 49.36M sh · $17.87B · Q2 2026
- STATE STREET CORP 30.55M sh · $10.75B · Q1 2026
- Capital World Investors 29.08M sh · $10.53B · Q2 2026
- Capital World Investors 29.08M sh · $10.53B · Q2 2026
- Invesco Ltd 16.32M sh · $5.91B · Q2 2026
- Charles Schwab Investment Management 15.03M sh · $5.44B · Q2 2026
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 15.03M sh · $5.44B · Q2 2026
- Sixth Street Partners Management Company, L.P. 15.03M sh · $5.44B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 6.76M sh · $2.45B · Q2 2026
- UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME 5.39M sh · $1.95B · Q2 2026
- Aristotle Capital Management, LLC 2.92M sh · $1.06B · Q2 2026
- STATE FARM MUTUAL AUTOMOBILE INSURANCE CO 2.72M sh · $983.39M · Q2 2026
More on Sarasin & Partners LLP
FAQ
How long has Sarasin & Partners LLP held AMGN?
Sarasin & Partners LLP has disclosed AMGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Sarasin & Partners LLP's current position in AMGN?
As of Q3 2026, Sarasin & Partners LLP holds 180.23K shares of AMGN (AMGEN INC), valued at $75.97M, representing 0.85% of its reported portfolio and ranking #34.
Has Sarasin & Partners LLP been buying or selling AMGN?
In the latest 13F filing (Q3 2026), Sarasin & Partners LLP reduced its position in AMGN. The position peaked in Q2 2024 at 1.13M shares.
Which other funds hold AMGN?
Other major institutional holders of AMGN include BlackRock Inc, STATE STREET CORP, Capital World Investors, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.